GPC3 and hepatocellular carcinoma: The potent antitumor activity of GPC3-specific NK cells was observed in multiple HCC xenografts with both high and low GPC3 expression but not in those without GPC3 expression [180], which extends the treatment options for HCC patients with high GPC-3 expression.